Harborside


AMP Alternative Medical Products Inc.

CNSX: XCX


Canadian symbol: XCX.CN
US symbol:

Currency in CAD

Valuation Measures

Market Cap (intraday) 511.76M
Enterprise Value 312.66M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)34.33
Price/Book (mrq)N/A
Enterprise Value/Revenue 336.95
Enterprise Value/EBITDA 7N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.16
52-Week Change 3-3.75%
S&P500 52-Week Change 334.98%
52 Week High 30.8800
52 Week Low 30.0000
50-Day Moving Average 30.3110
200-Day Moving Average 30.3598

Share Statistics

Avg Vol (3 month) 34.01k
Avg Vol (10 day) 38.22k
Shares Outstanding 530.56M
Implied Shares Outstanding 6N/A
Float 22.74M
% Held by Insiders 134.90%
% Held by Institutions 10.00%
Shares Short (May 30, 2021) 42.5k
Short Ratio (May 30, 2021) 40.72
Short % of Float (May 30, 2021) 4N/A
Short % of Shares Outstanding (May 30, 2021) 40.01%
Shares Short (prior month Mar. 30, 2021) 413.43k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4May 02, 2012
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-630.06%

Management Effectiveness

Return on Assets (ttm)-240.35%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)342.67k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-153
EBITDA N/A
Net Income Avi to Common (ttm)-2.37M
Diluted EPS (ttm)-0.1270
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)259.63k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)1.46M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.99
Book Value Per Share (mrq)-0.03

Cash Flow Statement

Operating Cash Flow (ttm)-1.85M
Levered Free Cash Flow (ttm)-1.08M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
XCX.CN
AMP Alternative Medical Products
9 months ago
XCX.CN
AMP Alternative Medical Products
1 year ago
XCX.CN
AMP Alternative Medical Products
1 year ago
XCX.CN
AMP Alternative Medical Products
1 year ago
XCX.CN
AMP Alternative Medical Products
1 year ago
XCX.CN
AMP Alternative Medical Products
1 year ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
34.90%% of Shares Held by All Insider
0.00%% of Shares Held by Institutions
0.00%% of Float Held by Institutions
0Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by AMP Alternative Medical Products Inc.


AMP Alternative Medical Products and Waldhausklinik Deuringen Announce Clinical Study into the Effects of Medical Cannabis

AMP Alternative Medical Products and Waldhausklinik Deuringen Announce Clinical Study into the Effects of Medical Cannabis

ERFURT, Germany and BERLIN and STADTBERGEN, Germany, Sept. 13, 2021 - AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis products to German pharmacies, and WaldhausKlinik Deuringen gGmbH ("Waldhausklinik"), a  non-profit acute care hospital for internal me... Read More...
AMP Launches its CBD Brand, CANAVEX¬ģ at YES!CON, Germany's Largest Cancer Convention

AMP Launches its CBD Brand, CANAVEX¬ģ at YES!CON, Germany’s Largest Cancer Convention

AMP created CANAVEX¬ģ¬†for cosmetic use and sold exclusively by pharmacists without a doctor's prescription.¬† CANAVEX¬ģ¬†formulation includes high quality CBD, which is sourced from Germany and EU-GMP compliant, organic hemp seed oil and vitamin E. CANAVEX¬ģ's initial products are Basic CBD 5, which contains 500mg or 5% CBD and Basic CBD 10, w... Read More...
AMP German Cannabis Group and Aphria's subsidiary CC Pharma GmbH enter into Strategic Co-Promotion Agreement for the Sale of Medical Cannabis in Germany

AMP German Cannabis Group and Aphria’s subsidiary CC Pharma GmbH enter into Strategic Co-Promotion Agreement for the Sale of Medical Cannabis in Germany

ERFURT/BERLIN/DENSBORN, Germany, and LEAMINGTON, ON, Canada, Jan. 26, 2021 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028) and Aphria Inc.'s ("Aphria") (TSX: APHA) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH ("CC Pharma"), have entered into a strategic agreement (the "Co-Promoti... Read More...
AMP German Cannabis Group Provides Year-end Letter to Shareholders

AMP German Cannabis Group Provides Year-end Letter to Shareholders

ERFURT, Germany and BERLIN, Dec. 16, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (Frankfurt: C4T) (ISIN: CA00176G1028) is pleased to provide a letter to its shareholders. Dear Shareholders, The upcoming year will be transformational for AMP and the medical cannabis industry in Germany and globally. AMP's focus has always b... Read More...
AMP Presents Round Table Discussion on Medical Cannabis in the Focus of German Politics with Dr. Wieland Schinnenburg, MdB (FDP)

AMP Presents Round Table Discussion on Medical Cannabis in the Focus of German Politics with Dr. Wieland Schinnenburg, MdB (FDP)

ERFURT, Germany and BERLIN, Nov. 30, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) is proud to present the second episode of its "Round Table" series with Dr. Wieland Schinnenburg, MdB of the FDP, who provides an up-to-date overview of the political issues and challenges facing the medical cannab... Read More...
AMP German Cannabis Group enters into long term supply agreement with Danish medical cannabis producer Schroll Medical

AMP German Cannabis Group enters into long term supply agreement with Danish medical cannabis producer Schroll Medical

ERFURT, Germany and BERLIN and ÅRSLEV, Denmark, Nov. 5, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028), providing German patients with a wide range of pharmaceutical grade medical cannabis products and Schroll Medical ApS ("Schroll"), a Danish cultivator of medical cannabis, announce that t... Read More...
AMP German Cannabis Group adds Little Green Pharma medical cannabis extracts from Australia to its sales offering

AMP German Cannabis Group adds Little Green Pharma medical cannabis extracts from Australia to its sales offering

AMP is looking forward to offering premium EU-GMP full plant extract cannabis oil medicines branded under the LGP Classic brand, produced by the same consistent strains.  AMP wants to introduce the LGP brand to the German market by selling "LGP Classic 20:5 Oils" (THC dominant) and additional products in the near term once AMP has establ... Read More...
AMP German Cannabis Group Hires Experienced Sales Director from Canopy Growth

AMP German Cannabis Group Hires Experienced Sales Director from Canopy Growth

ERFURT and BERLIN, Germany, Sept. 15, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028), a licenced importer of medical cannabis into Germany, is pleased to announce the appointment of Mr. Marc Wälken as Sales Director, effective immediately. Mr. Wälken joins AMP from Spectrum Therapeutics, a brand o... Read More...
AMP German Cannabis Group provides growth strategy update

AMP German Cannabis Group provides growth strategy update

Cannabis Shipment Volume Over First Two Months of Third Quarter ~20% Higher Than Cannabis Shipment Volume Over Entire Second QuarterVANCOUVER, BC, Aug. 31, 2020 - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") today announced that its first shipments to Australia from its Zenabis Atholville facility was completed on August 2... Read More...
AMP German Cannabis Group enters into Supply Agreement with Canadian Medical cannabis producer, Eve & Co

AMP German Cannabis Group enters into Supply Agreement with Canadian Medical cannabis producer, Eve & Co

ERFURT and BERLIN, Germany and TORONTO, Aug. 11, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) and Eve & Co. Incorporated ("Eve & Co.") (TSXV: EVE) (QTCQX: EEVVF) announce they have entered into a supply agreement for the purchase and export to Germany of European Union Good Manufacturing... Read More...
AMP German Cannabis Group Presents Roundtable Discussion with European Medical Cannabis Expert, Dr. Franjo Grotenhermen and Dr. Stefan Feuerstein about Medical Cannabis in Germany

AMP German Cannabis Group Presents Roundtable Discussion with European Medical Cannabis Expert, Dr. Franjo Grotenhermen and Dr. Stefan Feuerstein about Medical Cannabis in Germany

ERFURT and BERLIN, Germany, Aug. 4, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) proudly presents its first video in a series of in-depth roundtable discussions that will explore and discuss new developments regarding medical cannabis in Germany. The Roundtable Series online videos are in German... Read More...
AMP German Cannabis Group orders 150 kilograms of medical cannabis from Canadian Licensed Producer

AMP German Cannabis Group orders 150 kilograms of medical cannabis from Canadian Licensed Producer

ERFURT and BERLIN, Germany, July 21, 2020 - AMP German Cannabis Group Inc. ("AMP") (FSE: C4T) (ISIN: CA00176G1028) (CSE: XCX) announces it has placed two orders for bulk and finished EU-GMP medical cannabis flower from a Canadian Licensed Producer ("Canadian LP") of medical cannabis. AMP will be purchasing and importing to Germany, 50 kil... Read More...
AMP German Cannabis Group to begin medical cannabis imports from the Netherlands

AMP German Cannabis Group to begin medical cannabis imports from the Netherlands

ERFURT and BERLIN, Germany, July 6, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) announces further to its June 5, 2020 news release The Office of Medical Cannabis ("OMC"), the government organization of the Netherlands for distribution of medical cannabis products, has notified AMP that it will r... Read More...
AMP German Cannabis Group announces AGM results and appointment of new CFO

AMP German Cannabis Group announces AGM results and appointment of new CFO

ERFURT and BERLIN, Germany , June 29, 2020 - AMP German Cannabis Group Inc. ("AMP") (C4T.F) (ISIN:CA00176G1028) (XCX.CN) held its annual general meeting of shareholders (AGM) earlier today. The shareholders approved all resolutions put before them, namely:Re-electing Dr. Stefan Feuerstein and Messrs. Alex Blodgett , Claudio Morandi and Ke... Read More...
AMP German Cannabis Group to develop medical cannabis brands for the German market

AMP German Cannabis Group to develop medical cannabis brands for the German market

AMP is fully licenced to import medical cannabis from Europe and other countries Building brands for the German medical cannabis market supplied by foreign licenced producers Large volume Canadian imports projected to begin in the fall of 2020 under AMP brand ERFURT, Germany and BERLIN, June 8, 2020 - AMP German Cannabis Group Inc. ("... Read More...
AMP German Cannabis Group sets date for Annual General Meeting and Online Question & Answer Session

AMP German Cannabis Group sets date for Annual General Meeting and Online Question & Answer Session

ERFURT, Germany and BERLIN , June 2, 2020 - AMP German Cannabis Group Inc. ("AMP") (XCX.CN) (FSE: C4T, ISIN: CA00176G1028) will hold its Annual General Meeting of Shareholders (AGM) on Monday, June 29 th, 2020, beginning at 3:00 p.m. Central European Time (6:00 a.m. Pacific Standard Time) to conduct formal business follow by an online que... Read More...
AMP German Cannabis Group Receives Irradiation Licence for Medical Cannabis Imports into Germany

AMP German Cannabis Group Receives Irradiation Licence for Medical Cannabis Imports into Germany

BERLIN, April 14, 2020 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) is pleased to announce it has successfully obtained all the required licences to import, store at its licensed narcotic storage facility and distribute to its pharmaceutical distributors irradiated EU-GMP certified medical cannabis fl... Read More...
AMP German Cannabis Group Receives Import Licence for Medical Cannabis for Imports from European Union Countries

AMP German Cannabis Group Receives Import Licence for Medical Cannabis for Imports from European Union Countries

BERLIN, March 9, 2020 - AMP German Cannabis Group Inc. ("AMP")¬†(CSE: XCX) (FSE: C4T, ISIN:¬†CA00176G1028) announces that the Thuringian State Office for Consumer Protection or Th√ľringer Landesamt f√ľr Verbraucherschutz, ("TLV")¬†has granted an additional import licence for cannabis products for medical purposes from European countries to Ger... Read More...
AMP German Cannabis Group Receives an Import Licence for Medical Cannabis from the German State of Thuringia

AMP German Cannabis Group Receives an Import Licence for Medical Cannabis from the German State of Thuringia

BERLIN and ERFURT, Germany, Nov. 18, 2019 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces the Thuringian State Office for Consumer Protection (Thueringer Landesamt fuer Verbraucherschutz) ("TLV") has granted an import licence for cannabis products for medical purposes for Germany accordi... Read More...
AMP German Cannabis Group Signs Distribution Agreement with CC Pharma, a Wholly Owned Subsidiary of Aphria and a Leading Pharmaceutical and Medical Cannabis Distributer in Germany

AMP German Cannabis Group Signs Distribution Agreement with CC Pharma, a Wholly Owned Subsidiary of Aphria and a Leading Pharmaceutical and Medical Cannabis Distributer in Germany

AMP to supply the growing Germany market with pharmaceutical medical cannabis imported from Canada ERFURT, Germany and BERLIN, Oct. 15, 2019 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) through its wholly-owned subsidiary AMP Alternative Medical Products GmbH ("AMP Germany") has entered into a ... Read More...
AMP German Cannabis Group begins EU-GMP audit of its medical cannabis supply chain in Germany

AMP German Cannabis Group begins EU-GMP audit of its medical cannabis supply chain in Germany

BERLIN, Oct. 10, 2019 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces that it has begun conducting an European Union (EU) Good Manufacturing Procedure (EU-GMP) audit of its supply chain logistics in Germany to ensure that the quality and integrity of pharmaceutical goods during transport... Read More...
AMP German Cannabis Group Enters into memorandum of understanding supply agreement for the import of EU-GMP medical cannabis into Germany

AMP German Cannabis Group Enters into memorandum of understanding supply agreement for the import of EU-GMP medical cannabis into Germany

BERLIN, Oct. 8, 2019 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces that it has entered into a non-binding memorandum of understanding to purchase up to 1,200 kilograms of either branded or white-labeled European Union - Good Manufacturing Practice (EU-GMP) medical cannabis flower annua... Read More...
AMP German Cannabis Group Supplier, Pure Life Cannabis, Completes EU-GMP Gap Analysis

AMP German Cannabis Group Supplier, Pure Life Cannabis, Completes EU-GMP Gap Analysis

BERLIN, Sept. 17, 2019 - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces that one of its prospective medical cannabis supplier, Pure Life Cannabis Corp. ("Pure Life"), has completed its European Union Good Manufacturing Practice ("EU-GMP") gap analysis and will und... Read More...
Coming Soon.

Delayed data (1h)


Share this page